New Zealand Gazette – 1994 – No. 36

Page 1391

✨ Medicines Act Notices



21 APRIL NEW ZEALAND GAZETTE 1391

Dated at Wellington this 19th day of April 1994.
Hon JENNY SHIPLEY, Minister of Health.
go9289

Medicines Act 1981

Corrigendum

Consent to the Distribution of New Medicines

In the notice published in the New Zealand Gazette,
31 March 1994, No. 30, notice number 2463, page 1245.

Delete the phrase “Gemfibrozil 300 mg” in the nineteenth line. The active ingredients for Codal Tension Headache tablet are then correctly shown as “codeine phosphate 8 mg, doxylamine succinate 5 mg and paracetamol 500 mg”.

Dated at Wellington this 13th day of April 1994.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go7844

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Interferon alpha-2c 3 mcg, 6mcg, 15 mcg per ml Powder for reconstitution for injection Bender & Co GmbH, Vienna, Austria Berofor

Note: This replaces the entry in the notice published in the New Zealand Gazette, 25 November 1993, No. 172, page 3522, notice number 10002.

| Captopril 5 mg/ml in 100 ml | Oral solution | Bristol-Myers Squibb Pharmaceuticals Limited, Moreton, Wirral, Merseyside, England | Capoten |
Note: This replaces the entry in the notice published in the New Zealand Gazette, 24 March 1994, No. 27, page 1176, notice number 2120.

| Captopril 12.5 mg, 25 mg, 50 mg | Tablets | Bristol-Myers Squibb Pharmaceuticals Limited, Moreton, Wirral, Merseyside, England and Bristol-Myers Squibb Pharmaceuticals Pty Limited, Noble Park, Victoria, Australia | Capoten |
Note: This replaces the entry in the notice published in the New Zealand Gazette, 24 March 1994, No. 27, page 1176, notice number 2120.

Dated this 13th day of April 1994.

C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go2845

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
D-galactose 38% w/v Granules and solution for injection (contrast agent) Schering AG, Berlin, Germany Echovist 200

Note: This replaces the entry in the notice published in the New Zealand Gazette, 17 March 1994, No. 25, page 1115, notice number 1973.

| D-galactose 45% w/v | Granules and solution for injection (contrast agent) | Schering AG, Berlin, Germany | Echovist 300 |



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa — PDF NZ Gazette 1994, No 36


NZLII — PDF NZ Gazette 1994, No 36




✨ LLM interpretation of page content

🏥 Corrigendum to Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
13 April 1994
Medicines, Corrigendum, Gemfibrozil, Codal Tension Headache
  • C. Lovelace, Director-General of Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
13 April 1994
Medicines, Distribution, Interferon alpha-2c, Captopril
  • C. Lovelace, Director-General of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
13 April 1994
Medicines, Distribution, D-galactose, Echovist
  • C. Lovelace, Director-General of Health